T1	PROC 47 110	Estudio de extensión de un único brazo, abierto y multicéntrico
T2	DISO 128 143	tumores sólidos
#1	AnnotatorNotes T2	C0280100; Solid Neoplasm; Neoplastic Process
T3	PROC 156 167	tratamiento
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	PROC 286 320	Estudio de extensión multicéntrico
T5	DISO 338 353	tumores sólidos
#3	AnnotatorNotes T5	C0280100; Solid Neoplasm; Neoplastic Process
T6	PROC 366 377	tratamiento
#4	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	DISO 503 518	Tumores sólidos
#5	AnnotatorNotes T7	C0280100; Solid Neoplasm; Neoplastic Process
T8	DISO 540 546	Cáncer
#6	AnnotatorNotes T8	C0006826; Malignant Neoplasms; Neoplastic Process
T9	PROC 602 615	procedimiento
#7	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T10	PROC 728 739	tratamiento
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 659 695	consentimiento informado por escrito
#9	AnnotatorNotes T11	C0811741; Obtain informed written consent; Health Care Activity
T12	PROC 916 940	continuar el tratamiento
#10	AnnotatorNotes T12	C2091305; continue current medication; Therapeutic or Preventive Procedure
T13	PROC 992 1001	protocolo
#11	AnnotatorNotes T13	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T14	PROC 1054 1063	protocolo
#12	AnnotatorNotes T14	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T15	PROC 1238 1259	método anticonceptivo
#13	AnnotatorNotes T15	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T16	PROC 1288 1307	ensayo de extensión
T17	CHEM 1368 1378	medicación
#14	AnnotatorNotes T17	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T18	PROC 1383 1402	ensayo de extensión
T19	DISO 1433 1470	Signos de progresión de la enfermedad
T20	PROC 1492 1501	protocolo
#15	AnnotatorNotes T20	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T21	DISO 1567 1573	Signos
#16	AnnotatorNotes T21	C0311392; Physical findings; Finding
T22	DISO 1587 1609	acontecimiento adverso
#17	AnnotatorNotes T22	C0877248; Adverse event; Pathologic Function
T23	CHEM 1639 1650	bevacizumab
#18	AnnotatorNotes T23	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T24	PROC 1748 1776	Interrupción del tratamiento
#19	AnnotatorNotes T24	C0850893; stop medication; Therapeutic or Preventive Procedure
T25	CHEM 1841 1852	bevacizumab
#20	AnnotatorNotes T25	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T26	DISO 1872 1878	Signos
#21	AnnotatorNotes T26	C0311392; Physical findings; Finding
T27	DISO 1897 1907	enfermedad
#22	AnnotatorNotes T27	C0012634; Disease; Disease or Syndrome
T28	DISO 1909 1944	disfunción neurológica o metabólica
T29	PROC 1962 1980	exploración física
#23	AnnotatorNotes T29	C0031809; Physical Examination; Health Care Activity
T30	DISO 2046 2056	enfermedad
#24	AnnotatorNotes T30	C0012634; Disease; Disease or Syndrome
T31	DISO 2059 2068	trastorno
#25	AnnotatorNotes T31	C0012634; Disease; Disease or Syndrome
T32	CHEM 2100 2124	fármaco en investigación
#26	AnnotatorNotes T32	C0013230; Investigational New Drugs; Pharmacologic Substance
T33	DISO 2185 2199	complicaciones
#27	AnnotatorNotes T33	C0009566; Complication; Pathologic Function
T34	PROC 2220 2231	tratamiento
#28	AnnotatorNotes T34	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T35	CHEM 172 183	bevacizumab
#29	AnnotatorNotes T35	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T36	CHEM 382 393	bevacizumab
#30	AnnotatorNotes T36	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T37	CHEM 744 755	bevacizumab
#31	AnnotatorNotes T37	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T38	CHEM 945 956	bevacizumab
#32	AnnotatorNotes T38	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T39	PROC 1699 1743	interrupción definitiva de la administración
T40	CHEM 1781 1792	bevacizumab
#33	AnnotatorNotes T40	C0796392; bevacizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T41	Date 12 16	2011
T42	LIVB 114 123	pacientes
#34	AnnotatorNotes T42	C0030705; Patients; Patient or Disabled Group
T43	LIVB 324 333	pacientes
#35	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T45	LIVB 703 711	paciente
#36	AnnotatorNotes T45	C0030705; Patients; Patient or Disabled Group
T46	LIVB 870 882	investigador
#37	AnnotatorNotes T46	C0035173; Research Personnel; Professional or Occupational Group
T47	LIVB 890 898	paciente
#38	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	LIVB 1022 1030	paciente
#39	AnnotatorNotes T48	C0030705; Patients; Patient or Disabled Group
T49	LIVB 1095 1102	mujeres
#40	AnnotatorNotes T49	C0043210; Woman; Population Group
T50	Neg_cue 1103 1105	no
T51	Neg_cue 1130 1132	ni
T52	LIVB 1165 1198	mujeres con capacidad de procrear
#41	AnnotatorNotes T52	C4324275; Woman of childbearing potential; Population Group
T53	PHYS 1177 1198	capacidad de procrear
#42	AnnotatorNotes T53	C3831118; Childbearing Potential; Clinical Attribute
T54	LIVB 1201 1208	varones
#43	AnnotatorNotes T54	C0025266; Male population group; Population Group
T55	Duration 1318 1334	al menos 6 meses
T56	CONC 1349 1361	última dosis
T58	Duration 1801 1815	más de 42 días
T59	CONC 1825 1837	última dosis
T60	PHYS 1934 1944	metabólica
#44	AnnotatorNotes T60	C0025519; Metabolism; Organism Function
T61	Spec_cue 2018 2027	sospechas
T62	Spec_cue 2143 2149	riesgo
T63	LIVB 2166 2174	paciente
#45	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	PHYS 1118 1129	embarazadas
#46	AnnotatorNotes T64	C0032961; Pregnancy; Organism Function
T65	PHYS 1147 1156	lactancia
#47	AnnotatorNotes T65	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
A2	Assertion T64 Negated
A3	Assertion T65 Negated
A4	Assertion T30 Speculated
A5	Assertion T31 Speculated
A6	Assertion T33 Speculated
A7	Status T40 History_of
A8	Status T25 History_of
A9	Assertion T32 Contraindicated
#48	AnnotatorNotes T19	C4716499; Signs and symptoms of disease progression; Finding
T57	Spec_cue 1610 1624	potencialmente
T66	Quantifier_or_Qualifier 1625 1635	atribuible
A10	Assertion T66 Speculated
#49	AnnotatorNotes T66	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept
R1	Before Arg1:T11 Arg2:T9	
R2	Negation Arg1:T50 Arg2:T64	
R3	Negation Arg1:T51 Arg2:T65	
T44	Quantifier_or_Qualifier 1260 1276	de alta eficacia
R4	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T44	
R5	Speculation Arg1:T57 Arg2:T66	
R6	Speculation Arg1:T61 Arg2:T30	
R7	Speculation Arg1:T61 Arg2:T31	
R8	Speculation Arg1:T62 Arg2:T33	
R9	Experiences Arg1:T63 Arg2:T33	
R10	Causes Arg1:T34 Arg2:T33	
R11	Experiences Arg1:T63 Arg2:T34	
R12	Experiences Arg1:T42 Arg2:T2	
R13	Experiences Arg1:T42 Arg2:T3	
R14	Used_for Arg1:T35 Arg2:T3	
R15	Experiences Arg1:T43 Arg2:T5	
R16	Experiences Arg1:T43 Arg2:T6	
R17	Used_for Arg1:T36 Arg2:T6	
R18	Experiences Arg1:T45 Arg2:T10	
R19	Used_for Arg1:T37 Arg2:T10	
T67	CONC 759 775	final del ensayo
#50	AnnotatorNotes T67	C2983670; Study End Date; Temporal Concept
R20	Overlap Arg1:T10 Arg2:T67	
T68	Observation 829 847	efectos beneficios
R21	Causes Arg1:T10 Arg2:T68	
R22	Experiences Arg1:T45 Arg2:T68	
R23	Experiences Arg1:T47 Arg2:T12	
R24	Used_for Arg1:T38 Arg2:T12	
T69	CONC 960 976	final del ensayo
#51	AnnotatorNotes T69	C2983670; Study End Date; Temporal Concept
R25	Overlap Arg1:T12 Arg2:T69	
T70	Observation 1034 1063	capaz de cumplir el protocolo
#52	AnnotatorNotes T70	C0582783; Ability to comply with treatment; Finding (?)
R26	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T70	
R27	Experiences Arg1:T49 Arg2:T64	
R28	Experiences Arg1:T49 Arg2:T65	
R29	Experiences Arg1:T52 Arg2:T15	
T71	Quantifier_or_Qualifier 1209 1217	fértiles
R30	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T71	
R31	Experiences Arg1:T54 Arg2:T15	
R32	Overlap Arg1:T15 Arg2:T16	
R33	Has_Duration_or_Interval Arg1:T15 Arg2:T55	
R34	After Arg1:T15 Arg2:T56	
R35	Has_Dose_or_Strength Arg1:T17 Arg2:T56	
R36	After Arg1:T15 Arg2:T18	
R37	Experiences Arg1:T52 Arg2:T53	
R38	Experiences Arg1:T52 Arg2:T17	
R39	Experiences Arg1:T54 Arg2:T17	
T72	PROC 1534 1543	selección
#53	AnnotatorNotes T72	C0242802; Patient Selection; Research Activity
R40	Overlap Arg1:T19 Arg2:T72	
R41	Causes Arg1:T22 Arg2:T21	
R42	Before Arg1:T23 Arg2:T22	
R43	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T66	
R44	Used_for Arg1:T23 Arg2:T39	
R45	Before Arg1:T22 Arg2:T39	
#54	AnnotatorNotes T39	C0850893; stop medication; Therapeutic or Preventive Procedure (?)
R46	Used_for Arg1:T40 Arg2:T24	
R48	After Arg1:T24 Arg2:T59	
R49	Has_Dose_or_Strength Arg1:T25 Arg2:T59	
R50	Has_Duration_or_Interval Arg1:T24 Arg2:T58	
R47	Causes Arg1:T27 Arg2:T26	
R51	Causes Arg1:T28 Arg2:T26	
#55	AnnotatorNotes T28	C0751377; Neurologic Dysfunction; Finding | C4062570; Alteration in metabolism; Finding (?)
T73	Observation 1946 1980	hallazgos en la exploración física
#56	AnnotatorNotes T73	C0311392; Physical findings; Finding
R54	Experiences Arg1:T63 Arg2:T26	
R55	Experiences Arg1:T63 Arg2:T27	
R56	Experiences Arg1:T63 Arg2:T28	
R57	Experiences Arg1:T63 Arg2:T60	
R58	Experiences Arg1:T63 Arg2:T73	
R59	Experiences Arg1:T63 Arg2:T29	
R60	Experiences Arg1:T63 Arg2:T30	
R61	Experiences Arg1:T63 Arg2:T31	
R62	Before Arg1:T31 Arg2:T32	
R63	Before Arg1:T30 Arg2:T32	
R65	Before Arg1:T26 Arg2:T32	
R66	Before Arg1:T27 Arg2:T32	
R67	Before Arg1:T28 Arg2:T32	
R68	Before Arg1:T73 Arg2:T32	
R69	Before Arg1:T29 Arg2:T32	
R70	Before Arg1:T32 Arg2:T33	
#57	AnnotatorNotes T68	C4049461; Unexpected beneficial therapeutic response; Finding (?)
#58	AnnotatorNotes R49	(?)
#59	AnnotatorNotes T59	C1762893; Date last dose; Temporal Concept
#60	AnnotatorNotes R35	(?)
#61	AnnotatorNotes T56	C1762893; Date last dose; Temporal Concept
A1	Experiencer T63 Patient
A11	Experiencer T42 Patient
A12	Experiencer T43 Patient
A13	Experiencer T45 Patient
A14	Experiencer T46 Other
A15	Experiencer T47 Patient
A16	Experiencer T48 Patient
A17	Experiencer T49 Patient
A18	Experiencer T52 Patient
A19	Experiencer T54 Patient
